"10.1371_journal.pone.0001465","plos one","2008-01-23T00:00:00Z","Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Dapa A Diallo; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Alassane Dicko; Issaka Sagara; Mahamadou S Sissoko; Mounirou Baby; Mady Sissoko; Issa Diarra; Amadou Niangaly; Amagana Dolo; Modibo Daou; Sory I Diawara; D Gray Heppner; V Ann Stewart; Evelina Angov; Elke S Bergmann-Leitner; David E Lanar; Sheetij Dutta; Lorraine Soisson; Carter L Diggs; Amanda Leach; Alex Owusu; Marie-Claude Dubois; Joe Cohen; Jason N Nixon; Aric Gregson; Shannon L Takala; Kirsten E Lyke; Christopher V Plowe","Malaria Research and Training Center, University of Bamako, Bamako, Mali; Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D. C., United States of America; World Wide Clinical Development â€“ Malaria Vaccines, GlaxoSmithKline Biologicals, Rixensart, Belgium; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America","Conceived and designed the experiments: CP AG ID AN MD SID EB SD AO JC AL MT OD DD DC IS ADi EA LS KL AK CD DL ST ABG KT M-CD DH MB ADo. Performed the experiments: CP AG ID AN MD SID EB JN MT OD DD DC VS EA KL AK ST ABG KT MB MS ADo. Analyzed the data: CP EB MT IS ADi VS EA ST MSS. Contributed reagents/materials/analysis tools: SD JC AL VS EA DL M-CD DH. Wrote the paper: CP EB SD AO JC AL MT OD DD DC IS ADi VS EA LS KL CD DL ST M-CD DH MSS.","SD and DEL hold patents for the FMP2.1 vaccine antigen. AL, JC and MCD are employees of GlaxoSmithKline Biologicals, the manufacturer of the proprietary adjuvant AS02A, and hold shares in GlaxoSmithKline. None of the other authors have declared conflict of interest.","2008","01","Mahamadou A Thera","MAT",34,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
